Work

Human immunodeficiency virus and liver disease forum 2010: Conference proceedings

Year: 2010

Type: article

Abstract: Liver disease continues to represent a critical mediator of morbidity and mortality in those with human immunodeficiency virus (HIV) infection. The frequent presence and overlap of concomitant injurious processes, including hepatitis C virus and hepatitis B virus infections, hepatoxicity associated with antiretroviral therapeutic agents, alcohol, and other toxins, in the setting of immunosuppression lead to rapid fibrotic progression and early development of end-stage liver disease. This conference summary describes the proceedings of a state-of-the-art gathering of international experts designed to highlight the status of current research in epidemiology, natural history, pathogenesis, and treatment of HIV and liver disease.

Source: Hepatology

DOI: 10.1002/hep.24651

Authors: Kenneth E. Sherman, David L. Thomas, Raymond T. Chung

Institutions: University of Cincinnati, Johns Hopkins University, Johns Hopkins Medicine, Harvard University, Massachusetts General Hospital

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute on Alcohol Abuse and Alcoholism, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases